Scientific principles for mycophenolic acid therapeutic drug monitoringSHAW, L. M; KORECKA, M; ARADHYE, S et al.Transplantation proceedings. 1998, Vol 30, Num 5, pp 2234-2236, issn 0041-1345Conference Paper

Un nouvel immunosuppresseur : Cellcept = A new immunosuppressor: CellCeptMOULY-BANDINI, A.La Presse médicale (1983). 2001, Vol 30, Num 2, pp 66-67, issn 0755-4982Article

Mycophenolate mofetil: new applications for this immunosuppressantMODER, Kevin G.Annals of allergy, asthma, & immunology. 2003, Vol 90, Num 1, pp 15-20, issn 1081-1206, 6 p.Article

Mycophenolate mofetil is an effective treatment for peristomal pyoderma gangrenosumDANIELS, Natalie Houston; CALLEN, Jeffrey P.Archives of dermatology (1960). 2004, Vol 140, Num 12, pp 1427-1429, issn 0003-987X, 3 p.Article

Mycophenolate mofetil may serve as a steroid-sparing agent for sarcoidosisKOUBA, D. J; MIMOUNI, D; RENCIC, A et al.British journal of dermatology (1951). 2003, Vol 148, Num 1, pp 147-148, issn 0007-0963, 2 p.Article

Mycophenolatemofetil for immunosuppression after liver transplantation: A follow-up study of 191 patientsPFITZMANN, Robert; KLUPP, Jochen; LANGREHR, Jan Michael et al.Transplantation. 2003, Vol 76, Num 1, pp 130-136, issn 0041-1337, 7 p.Article

Mycophenolate mofetil reduces graft loss due to chronic allograft nephropathyFALKIEWICZ, K; KURIATA, M; BORATYNSKA, M et al.Transplantation proceedings. 2002, Vol 34, Num 2, pp 567-568, issn 0041-1345Conference Paper

Pharmacokinetics help optimizing mycophenolate mofetil dosing in kidney transplant patientsCATTANEO, Dario; GASPARI, Flavio; FERRARI, Silvia et al.Clinical transplantation. 2001, Vol 15, Num 6, pp 402-409, issn 0902-0063Article

Mycophenolate mofetil in cyclosporine-associated nephrotoxicityDUCLOUX, D; FOURNIER, V; BRESSON-VAUTRIN, C et al.Transplantation proceedings. 1998, Vol 30, Num 6, pp 2825-2827, issn 0041-1345Conference Paper

Treatment of steroid refractory inflammatory bowel disease (IBD) with mycophenolate mofetil (MMF)FLORIN, T. H. J; ROBERTS, R. K; WATSON, M. T et al.Australian and New Zealand journal of medicine. 1998, Vol 28, Num 3, pp 344-345, issn 0004-8291Conference Paper

Is the glucuronide metabolite of MPA pharmacologically active ?NOWAK, I; WU, J; BRAYMAN, K. L et al.Transplantation proceedings. 1997, Vol 29, Num 1-2, issn 0041-1345, p. 337Conference Paper

Effizienz von Mycophenolat-Mofetil bei der Therapie der intermediären und posterioren Uveitis = Efficiency of mycophenolate mofetil in the treatment of intermediate and posterior uveitisGREINER, K; VARIKKARA, M; SANTIAGO, C et al.Der Ophthalmologe (Berlin. Print). 2002, Vol 99, Num 9, pp 691-694, issn 0941-293XArticle

Pharmacokinetics of mycophenolate mofetil in eight pediatric renal transplant patientsAIGRAIN, E. J; SHAGHAGHI, E. K; BAUDOUIN, V et al.Transplantation proceedings. 2000, Vol 32, Num 2, pp 388-390, issn 0041-1345Conference Paper

Tolerance of mycophenolate mofetil is dependent on kidney functionPUGGIA, R; RIZZOLO, M; MARESCA, M.-C et al.Transplantation proceedings. 1998, Vol 30, Num 5, issn 0041-1345, p. 2228Conference Paper

Stability of i.v. mycophenolate mofetil in 5% dextrose injection in polyvinyl chloride infusion bagsCERTAIN, Eric; BETETA, Francisco; GOUDOU-SINHA, Carole et al.American journal of health-system pharmacy. 2002, Vol 59, Num 24, pp 2434-2439, issn 1079-2082, 6 p.Article

Withdrawal of mycophenolate mofetil in stable renal transplant recipientsKAPLAN, B; MEIER-KRIESCHE, H.-U; VAGHELA, M et al.Transplantation. 2000, Vol 69, Num 8, pp 1726-1728, issn 0041-1337Article

Enterohepatic circulation model for population pharmacokinetic analysisFUNAKI, T.Journal of pharmacy and pharmacology. 1999, Vol 51, Num 10, pp 1143-1148, issn 0022-3573Article

Late conversion to mycophenolate mofetil for chronic deterioration of renal allograft functionFRITSCHE, L; SPERSCHNEIDER, H; BUDDE, K et al.Transplantation proceedings. 1998, Vol 30, Num 5, issn 0041-1345, p. 2229Conference Paper

Mycophenolate mofetil in ongoing chronic kidney allograft dysfunctionSENN, B; ROCHAT, P; SCHWARZKOPF, A. K et al.Transplantation proceedings. 1998, Vol 30, Num 8, pp 4075-4076, issn 0041-1345Conference Paper

Treatment of chronic rejection in renal transplantation by mycophenolate mofetil (MMF) : A preliminary report of six-month experienceJIRASIRITHAM, S; SUMETHKUL, V; MAVICHAK, V et al.Transplantation proceedings. 1998, Vol 30, Num 7, pp 3576-3577, issn 0041-1345Conference Paper

Mycophenolate mofetil for the prevention of acute rejection of primary cadaveric kidney transplants : Status of the MYC 1866 study at 1 yearTransplantation proceedings. 1997, Vol 29, Num 1-2, pp 348-349, issn 0041-1345Conference Paper

Mycophenolate mofetil rescue therapy in liver transplant recipientsGAVLIK, A; GOLDBERG, M. G; MILLER, J. A et al.Transplantation proceedings. 1997, Vol 29, Num 1-2, pp 549-552, issn 0041-1345Conference Paper

Identification of glucoside and carboxyl-linked glucuronide conjugates of mycophenolic acid in plasma of transplant recipients treated with mycophenolate mofetilSHIPKOVA, M; ARMSTRONG, V. W; WIELAND, E et al.British journal of pharmacology. 1999, Vol 126, Num 5, pp 1075-1082, issn 0007-1188Article

Mycophenolate mofetil-based, cyclosporine-free induction and maintenance immunosuppression : First-3-months analysis of efficacy and safety in two cohorts of renal allograft recipientsZANKER, B; SCHNEEBERGER, H; ROTHENPIELER, U et al.Transplantation. 1998, Vol 66, Num 1, pp 44-49, issn 0041-1337Article

Does reduction in mycophenolic acid dose compromise efficacy regardless of tacrolimus exposure level? An analysis of prospective data from the Mycophenolic Renal Transplant (MORE) RegistryLANGONE, Anthony; DORIA, Cataldo; GREENSTEIN, Stuart et al.Clinical transplantation. 2013, Vol 27, Num 1, pp 15-24, issn 0902-0063, 10 p.Article